Literature DB >> 2017951

Factors affecting the development of pneumothorax associated with thoracentesis.

V Raptopoulos1, L M Davis, G Lee, C Umali, R Lew, R S Irwin.   

Abstract

This study is a retrospective survey of the variables that may influence the development of pneumothorax after thoracentesis. In a 30-month period, a computer search of hospital records identified 342 thoracenteses, of which 154 were done with conventional techniques by the clinical services, and 188 were done with sonographic guidance. Other factors surveyed included the patients' age, sex, underlying pulmonary disease, and overall clinical condition; the size of the effusion; the type of tap (diagnostic or therapeutic); the amount and type (exudate or transudate) of fluid acquired; and the size of the needles used. The technique used was the most significant single risk factor affecting the development of pneumothorax (18% for clinical vs 3% for sonography-guided thoracenteses). The incidence of pneumothorax decreased when a smaller amount of pleural fluid was aspirated (mean, 246 ml aspirated from patients who did not vs 472 ml from those who did develop pneumothorax) and when thin needles were used (4% pneumothorax with 20-gauge or smaller and 18% with larger than 20-gauge needles). The other factors surveyed did not influence the development of pneumothorax. Our results show that sonography-guided thoracentesis is complicated by pneumothorax significantly less often than is thoracentesis done with conventional techniques. Use of the smallest possible needle and aspiration of the smallest possible amount of fluid will also result in fewer cases of pneumothorax.

Entities:  

Mesh:

Year:  1991        PMID: 2017951     DOI: 10.2214/ajr.156.5.2017951

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  25 in total

1.  Creation of an innovative inpatient medical procedure service and a method to evaluate house staff competency.

Authors:  C Christopher Smith; Craig E Gordon; David Feller-Kopman; Grace C Huang; Saul N Weingart; Roger B Davis; Armin Ernst; Mark D Aronson
Journal:  J Gen Intern Med       Date:  2004-05       Impact factor: 5.128

Review 2.  Chest drainage.

Authors:  Shaunagh McDermott; Diane A Levis; Ronald S Arellano
Journal:  Semin Intervent Radiol       Date:  2012-12       Impact factor: 1.513

Review 3.  Point-of-care ultrasound (POCUS): unnecessary gadgetry or evidence-based medicine?

Authors:  Nicholas Smallwood; Martin Dachsel
Journal:  Clin Med (Lond)       Date:  2018-06       Impact factor: 2.659

4.  Safety and Tolerability of Vacuum Versus Manual Drainage During Thoracentesis: A Randomized Trial.

Authors:  Michal Senitko; Amrik S Ray; Terrence E Murphy; Katy L B Araujo; Kyle Bramley; Erin M DeBiasi; Margaret A Pisani; Kelsey Cameron; Jonathan T Puchalski
Journal:  J Bronchology Interv Pulmonol       Date:  2019-07

5.  Management of pleural effusion, empyema, and lung abscess.

Authors:  Hyeon Yu
Journal:  Semin Intervent Radiol       Date:  2011-03       Impact factor: 1.513

Review 6.  Bedside ultrasound in pediatric critical care: a review.

Authors:  Sushant Srinivasan; Timothy T Cornell
Journal:  Pediatr Crit Care Med       Date:  2011-11       Impact factor: 3.624

Review 7.  Diagnosis and management of malignant pleural effusions: state of the art in 2017.

Authors:  Neeraj R Desai; Hans J Lee
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

Review 8.  Complications of thoracentesis: incidence, risk factors, and strategies for prevention.

Authors:  Eric P Cantey; James M Walter; Thomas Corbridge; Jeffrey H Barsuk
Journal:  Curr Opin Pulm Med       Date:  2016-07       Impact factor: 3.155

9.  Pleural infection-current diagnosis and management.

Authors:  Andrew Rosenstengel
Journal:  J Thorac Dis       Date:  2012-04-01       Impact factor: 2.895

Review 10.  Ultrasound in the diagnosis and management of pleural effusions.

Authors:  Nilam J Soni; Ricardo Franco; Maria I Velez; Daniel Schnobrich; Ria Dancel; Marcos I Restrepo; Paul H Mayo
Journal:  J Hosp Med       Date:  2015-07-28       Impact factor: 2.960

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.